Skip Nav Destination
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study
Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia
Issue Archive
February 15 2007
In this Issue
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
PERSPECTIVE
REVIEW IN TRANSLATIONAL HEMATOLOGY
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia
Clinical Trials & Observations
Jeffrey E. Lancet,Ivana Gojo,Jason Gotlib,Eric J. Feldman,Jacqueline Greer,Jane L. Liesveld,Laura M. Bruzek,Lawrence Morris,Youn Park,Alex A. Adjei,Scott H. Kaufmann,Elizabeth Garrett-Mayer,Peter L. Greenberg,John J. Wright,Judith E. Karp
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Clinical Trials & Observations
Elihu Estey,Marcos de Lima,Raoul Tibes,Sherry Pierce,Hagop Kantarjian,Richard Champlin,Sergio Giralt
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
Clinical Trials & Observations
Maria Gabriella Mazzucconi,Paola Fazi,Sayla Bernasconi,Giulio De Rossi,Giuseppe Leone,Luigi Gugliotta,Nicola Vianelli,Giuseppe Avvisati,Francesco Rodeghiero,Angela Amendola,Carlo Baronci,Cecilia Carbone,Stefano Quattrin,Giuseppe Fioritoni,Giulio D'Alfonso,Franco Mandelli,for the Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study
Clinical Trials & Observations
Adrienne de Labarthe,Philippe Rousselot,Françoise Huguet-Rigal,Eric Delabesse,Francis Witz,Sébastien Maury,Delphine Réa,Jean-Michel Cayuela,Marie-Christine Vekemans,Oumedaly Reman,Agnès Buzyn,Arnaud Pigneux,Martine Escoffre,Yves Chalandon,Elizabeth MacIntyre,Véronique Lhéritier,Jean-Paul Vernant,Xavier Thomas,Norbert Ifrah,Hervé Dombret,for the Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
GENE THERAPY
Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
Amit C. Nathwani,John T. Gray,Jenny McIntosh,Catherine Y. C. Ng,Junfang Zhou,Yunyu Spence,Melanie Cochrane,Elaine Gray,Edward G. D. Tuddenham,Andrew M. Davidoff
HEMATOPOIESIS
Caspase-8 prevents sustained activation of NF-κB in monocytes undergoing macrophagic differentiation
Cédric Rébé,Séverine Cathelin,Sophie Launay,Rodolphe Filomenko,Laurent Prévotat,Coralie L'Ollivier,Emmanuel Gyan,Olivier Micheau,Steven Grant,Anne Dubart-Kupperschmitt,Michaëla Fontenay,Eric Solary
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Receptor activator of nuclear factor (NF)–κB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice
Jeong-Ki Min,Young-Lai Cho,Jae-Hoon Choi,Yonghak Kim,Jeong Hun Kim,Young Suk Yu,Jaerang Rho,Naoki Mochizuki,Young-Myeong Kim,Goo Taeg Oh,Young-Guen Kwon
IMMUNOBIOLOGY
NEOPLASIA
Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl)
Klaus Podar,Marc S. Raab,Jing Zhang,Douglas McMillin,Iris Breitkreutz,Yu-Tzu Tai,Boris K. Lin,Nikhil Munshi,Teru Hideshima,Dharminder Chauhan,Kenneth C. Anderson
Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias
Noria Harir,Christian Pecquet,Marc Kerenyi,Karoline Sonneck,Boris Kovacic,Remy Nyga,Marie Brevet,Isabelle Dhennin,Valerie Gouilleux-Gruart,Hartmut Beug,Peter Valent,Kaiss Lassoued,Richard Moriggl,Fabrice Gouilleux
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis
Fenghuang Zhan,Bart Barlogie,Varant Arzoumanian,Yongsheng Huang,David R. Williams,Klaus Hollmig,Mauricio Pineda-Roman,Guido Tricot,Frits van Rhee,Maurizio Zangari,Madhav Dhodapkar,John D. Shaughnessy, Jr
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL–positive leukemias identified by a proteomics approach
Stefan Balabanov,Artur Gontarewicz,Patrick Ziegler,Ulrike Hartmann,Winfried Kammer,Mhairi Copland,Ute Brassat,Martin Priemer,Ilona Hauber,Thomas Wilhelm,Gerold Schwarz,Lothar Kanz,Carsten Bokemeyer,Joachim Hauber,Tessa L. Holyoake,Alfred Nordheim,Tim H. Brümmendorf
RED CELLS
STEM CELLS IN HEMATOLOGY
TRANSFUSION MEDICINE
Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model
Brief Report
Christopher C. Silliman,Brian R. Curtis,Patricia M. Kopko,Samina Y. Khan,Marguerite R. Kelher,Randy M. Schuller,Baindu Sannoh,Daniel R. Ambruso
TRANSPLANTATION
Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study
K. Scott Baker,Kirsten K. Ness,Julia Steinberger,Andrea Carter,Liton Francisco,Linda J. Burns,Charles Sklar,Stephen Forman,Daniel Weisdorf,James G. Gurney,Smita Bhatia
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia
Clinical Trials & Observations
Vivian G. Oehler,Ted Gooley,David S. Snyder,Laura Johnston,Allen Lin,Carrie C. Cummings,Su Chu,Ravi Bhatia,Stephen J. Forman,Robert S. Negrin,Frederick R. Appelbaum,Jerald P. Radich
CORRESPONDENCE
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals